Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
US large, mid, and small-cap retirement index funds provide layered exposure to varying market segments. This intro covers allocation ideas and risk considerations.
26,127 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
As the EV market accelerates, investors face a key question: which stock—Rivian or Tesla—fits their risk tolerance an...
Bloom Energy has surged 497% over the past year, shaking up portfolios and headlines. This guide breaks down what the...
Thomas Siebel’s return as C3.AI CEO could reshape sales strategy and investor sentiment. This article breaks down wha...
A surprising stock move followed Tencent Music’s latest quarterly results, with growth overshadowed by a dip in users...
A big data-center lease helped Applied Digital stock soar, signaling strong demand for AI infrastructure. Learn what ...
When a foreign gift becomes a temporary presidential plane, it illuminates how public spending, asset management, and...
As AI brings new pricing for memory, Micron stands at the crossroads of momentum and valuation. This guide breaks dow...
Nvidia's latest investor update can signal big moves for the stock, but the right move depends on your goals, risk to...
Could two of Elon Musk's biggest ventures consolidate into a market-shaking powerhouse? We dive into the rumors, the ...
Prices for gold and silver swung recently, and SSR Mining stock moved with them. This guide breaks down whether you s...
The once-rate story has grown into a life-altering reality, as millions of homeowners stay put to protect a valuable ...